SIC
AVXL icon

SJS Investment Consulting’s Anavex Life Sciences AVXL Stock Holding History

SJS Investment Consulting’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$174 Buy
67
+5
+8% +$15 ﹤0.01% 2502
2026
Q1 		$191 Buy
+62
New +$269 ﹤0.01% 1993

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SJS Investment Consulting's AVXL Position: Q2 2026 in Review

SJS Investment Consulting increased its Anavex Life Sciences (AVXL) stake by 8.1% in Q2 2026, buying an estimated $15 and bringing the position to 67 shares worth $174. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

SJS Investment Consulting first reported a position in AVXL in Q1 2026 and has held it in 2 quarters since. The position peaked at $191 in Q1 2026. 96 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • SJS Investment Consulting held 67 shares of Anavex Life Sciences worth $174 as of Q2 2026.
  • SJS Investment Consulting bought 5 Anavex Life Sciences shares in Q2 2026, an estimated $15.
  • Anavex Life Sciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2502 holding.
  • SJS Investment Consulting first reported a position in Anavex Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • SJS Investment Consulting's Anavex Life Sciences position peaked at $191 in Q1 2026.
  • 96 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.